Coherus Oncology News, Coherus Oncology Quote, CHRS Quote

Coherus Oncology (NQ:CHRS) Delayed: 1.47 +0.06 (4.26%)

Prev. Close

$1.41

Today 6M 1Y 5Y

Open

$1.46

52 Wk High

$31.98

52 Wk Low

$12.04

Day High

$1.50

Day Low

$1.44

P/E

N/A

EPS

$-0.10

Volume

385,686

Friends, Peers and Foes (?): ALLO, ELVN, ONCY PYXS (more...)

ALERTS | RSS

Jul 22, 2026 01:36 PM Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
Jun 23, 2026 02:09 PM Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi
Jun 23, 2026 02:00 PM Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
Jun 15, 2026 04:41 PM Form 8-K Coherus Oncology, Inc. For: Jun 12
Jun 9, 2026 09:58 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Satvat Ali J.
Jun 9, 2026 06:43 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Karachun Rita A
Jun 9, 2026 06:43 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Newcomer Lee Nisley
Jun 9, 2026 06:42 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Ryan Michael Lee
Jun 9, 2026 06:41 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: O'Donnell-Tormey Jill
Jun 9, 2026 06:40 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Wahlstrom Mats

Entities mentioned with CHRS

View All Entities